Safety and Pharmacokinetics Evaluation Study According to the Dose of Camostat Mesylate in Healthy Volunteers
Clinical trial NCT04782505 · COMPLETED
Trial details
- NCT number
- NCT04782505
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-12
- Primary completion
- 2021-03-16
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.